Feminization of hepatic cytochrome P450s by nominal levels of growth hormone in the feminine plasma profile

NA Pampori and BH Shapiro

Laboratory of Biochemistry, University of Pennsylvania, School of Veterinary Medicine, Philadelphia 19104-6048, USA.

The feminine profile of continuous growth hormone secretion was restored at various concentrations to hypophysectomized, thyroxine- supplemented female rats to determine the minimum signaling concentrations of the hormone required to maintain female-like expression levels of gender-dependent hepatic cytochrome P450s (P450s). Rat growth hormone was infused by intraperitoneally implanted osmotic minipumps, and the resulting circulating concentrations and profiles were determined by radioimmunoassay of serially collected plasma samples. Restoration of feminine growth hormone profiles at 3% of physiological concentration completely suppressed male-specific CYP2C11, CYP2C13, CYP2A2, and CYP3A2. Although significant levels of female-dependent isoforms were expressed at this growth hormone concentration, their full expression required, somewhat higher plasma concentrations of the hormone; CYP2A1 and 5 alpha-reductase were increased to normal female levels with only 6-12% of physiological concentrations of the hormone, normal expression levels of CYP2C12 required approximately 12-25% physiological hormone levels, and CYP2C7 required approximately 25-50% of the normal growth hormone profile to attain female-like expression levels. When determined, protein and specific catalytic activities were in agreement with mRNA levels, supporting the conclusion that growth hormone regulates gender- dependent expression of P450 isoforms by transcription initiation. There was little effect of gender, hypophysectomy, or growth hormone replacement on CYP2C6, growth hormone receptor, and growth hormone- binding protein mRNAs. In contrast, insulin-like growth factor-1 mRNA was sexually dimorphic (male > female), virtually disappeared after hypophysectomy, and was restored to female-like levels with plasma growth hormone concentrations equaling 12-25% of normal. These findings demonstrate the effectiveness of nominal growth hormone concentrations (undetectable by available radioimmunoassay) in an otherwise feminine plasma profile to maintain female-like expression levels of gender- dependent P450s.

Volume 50, Issue 5, pp. 1148-1156, 11/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				C. Thangavel and B. H. Shapiro Inherent Sexually Dimorphic Expression of Hepatic CYP2C12 Correlated with Repressed Activation of Growth Hormone-Regulated Signal Transduction in Male Rats Drug Metab. Dispos., September 1, 2008; 36(9): 1884 - 1895. [Abstract] [Full Text] [PDF]

				V. Wauthier and D. J. Waxman Sex-Specific Early Growth Hormone Response Genes in Rat Liver Mol. Endocrinol., August 1, 2008; 22(8): 1962 - 1974. [Abstract] [Full Text] [PDF]

				R. N. Dhir, C. Thangavel, and B. H. Shapiro Attenuated Expression of Episodic Growth Hormone-Induced CYP2C11 in Female Rats Associated with Suboptimal Activation of the Jak2/Stat5B and Other Modulating Signaling Pathways Drug Metab. Dispos., November 1, 2007; 35(11): 2102 - 2110. [Abstract] [Full Text] [PDF]

				C. Thangavel and B. H. Shapiro A Molecular Basis for the Sexually Dimorphic Response to Growth Hormone Endocrinology, June 1, 2007; 148(6): 2894 - 2903. [Abstract] [Full Text] [PDF]

				M. G. Holloway, Y. Cui, E. V. Laz, A. Hosui, L. Hennighausen, and D. J. Waxman Loss of Sexually Dimorphic Liver Gene Expression upon Hepatocyte-Specific Deletion of Stat5a-Stat5b Locus Endocrinology, May 1, 2007; 148(5): 1977 - 1986. [Abstract] [Full Text] [PDF]

				C. Thangavel, W. Dworakowski, and B. H. Shapiro INDUCIBILITY OF MALE-SPECIFIC ISOFORMS OF CYTOCHROME P450 BY SEX-DEPENDENT GROWTH HORMONE PROFILES IN HEPATOCYTE CULTURES FROM MALE BUT NOT FEMALE RATS Drug Metab. Dispos., March 1, 2006; 34(3): 410 - 419. [Abstract] [Full Text] [PDF]

				R. N. Dhir, W. Dworakowski, C. Thangavel, and B. H. Shapiro Sexually Dimorphic Regulation of Hepatic Isoforms of Human Cytochrome P450 by Growth Hormone J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 87 - 94. [Abstract] [Full Text] [PDF]

				C. A. Wiwi and D. J. Waxman Role of Hepatocyte Nuclear Factors in Transcriptional Regulation of Male-specific CYP2A2 J. Biol. Chem., February 4, 2005; 280(5): 3259 - 3268. [Abstract] [Full Text] [PDF]

				N. Stahlberg, E. Rico-Bautista, R. M. Fisher, X. Wu, L. Cheung, A. Flores-Morales, G. Tybring, G. Norstedt, and P. Tollet-Egnell Female-Predominant Expression of Fatty Acid Translocase/CD36 in Rat and Human Liver Endocrinology, April 1, 2004; 145(4): 1972 - 1979. [Abstract] [Full Text] [PDF]

				R. N. Dhir and B. H. Shapiro Interpulse growth hormone secretion in the episodic plasma profile causes the sex reversal of cytochrome P450s in senescent male rats PNAS, December 9, 2003; 100(25): 15224 - 15228. [Abstract] [Full Text] [PDF]

				A. Kaufhold, P. K. Nigam, R. N. Dhir, and B. H. Shapiro Prevention of Latently Expressed CYP2C11, CYP3A2, and Growth Hormone Defects in Neonatally Monosodium Glutamate-Treated Male Rats by the N-Methyl-D-Aspartate Receptor Antagonist Dizocilpine Maleate J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 490 - 496. [Abstract] [Full Text] [PDF]

				R. N. Dhir, W. Dworakowski, and B. H. Shapiro Middle-Age Alterations in the Sexually Dimorphic Plasma Growth Hormone Profiles: Involvement of Growth Hormone-Releasing Factor and Effects on Cytochrome P450 Expression Drug Metab. Dispos., February 1, 2002; 30(2): 141 - 147. [Abstract] [Full Text] [PDF]

				M. C. Garcia, C. Thangavel, and B. H. Shapiro Epidermal Growth Factor Regulation of Female-Dependent CYP2A1 and CYP2C12 in Primary Rat Hepatocyte Culture Drug Metab. Dispos., February 1, 2001; 29(2): 111 - 120. [Abstract] [Full Text]

				N. A. Pampori, A. K. Agrawal, and B. H. Shapiro Infusion of Gender-Dependent Plasma Growth Hormone Profiles Into Intact Rats: Effects of Subcutaneous, Intraperitoneal, and Intravenous Routes of Rat and Human Growth Hormone on Endogenous Circulating Growth Hormone Profiles and Expression of Sexually Dimorphic Hepatic Cyp Isoforms Drug Metab. Dispos., January 1, 2001; 29(1): 8 - 16. [Abstract] [Full Text]

				N. A. Pampori and B. H. Shapiro Nominal Growth Hormone Pulses in Otherwise Normal Masculine Plasma Profiles Induce Intron Retention of Overexpressed Hepatic CYP2C11 with Associated Nuclear Splicing Deficiency Endocrinology, November 1, 2000; 141(11): 4100 - 4106. [Abstract] [Full Text] [PDF]

				A. K. Agrawal and B. H. Shapiro Latent Overexpression of Hepatic CYP2C7 in Adult Male and Female Rats Neonatally Exposed to Phenobarbital: A Developmental Profile of Gender-Dependent P450s J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 1027 - 1033. [Abstract] [Full Text]

				A. K. Agrawal and B. H. Shapiro Differential Expression of Gender-Dependent Hepatic Isoforms of Cytochrome P-450 by Pulse Signals in the Circulating Masculine Episodic Growth Hormone Profile of the Rat J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 228 - 237. [Abstract] [Full Text]

				N. A. Pampori and B. H. Shapiro Gender Differences in the Responsiveness of the Sex-Dependent Isoforms of Hepatic P450 to the Feminine Plasma Growth Hormone Profile Endocrinology, March 1, 1999; 140(3): 1245 - 1254. [Abstract] [Full Text]

				A. K. Agrawal and B. H. Shapiro Gender, Age and Dose Effects of Neonatally Administered Aspartate on the Sexually Dimorphic Plasma Growth Hormone Profiles Regulating Expression of the Rat Sex-Dependent Hepatic CYP Isoforms Drug Metab. Dispos., November 1, 1997; 25(11): 1249 - 1256. [Abstract] [Full Text]

				A. Yamada, M. Yamada, Y. Fujita, T. Nishigami, K. Nakasho, and K. Uematsu Self-augmentation Effect of Male-specific Products on Sexually Differentiated Progesterone Metabolism in Adult Male Rat Liver Microsomes J. Biol. Chem., February 9, 2001; 276(7): 4604 - 4610. [Abstract] [Full Text] [PDF]